Picture of DNA Link logo

127120 DNA Link Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for DNA Link, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13,118-13,773-6,191-8,078-5,596
Depreciation
Amortisation
Non-Cash Items8,8647,2465,5574,0771,900
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital8265,239-7,4843,019-2,861
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,299849-6,429910-5,030
Capital Expenditures-2,576-1,098-4,020-4,932-2,876
Purchase of Fixed Assets
Other Investing Cash Flow Items-1,5772,657-19,0572,256-841
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-4,1531,559-23,077-2,675-3,717
Financing Cash Flow Items1000-83
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities31.728,238-1,6886,6494,579
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5,42130,549-31,0764,863-4,164